胃保留性尼扎替丁漂浮微丸的研制与评价

IF 0.4 Q4 PHARMACOLOGY & PHARMACY
Keyur S. Patel
{"title":"胃保留性尼扎替丁漂浮微丸的研制与评价","authors":"Keyur S. Patel","doi":"10.22377/ajp.v14i4.3818","DOIUrl":null,"url":null,"abstract":"Aim: The aim of the study was to develop gastroretentive floating pellets containing H2 –receptor antagonist, nizatidine which is primarily absorbed from stomach and has low oral bioavailability. Materials and Methods: The gastroretentive floating pellets of nizatidine were formulated using hydroxypropyl methylcellulose (HPMC) K100M and ethyl cellulose (EC) as sustained-release polymer, and NaHCO3 as a gas-forming agent. Pellets were prepared by extrusion–spheronization technique using microcrystalline cellulose as spheronizing agent. A 32 full factorial design was applied to investigate the effect of the two independent variables, that is, concentration of HPMC K100M (X1) and concentration of EC (X2) on the dependent variables, in vitro drug release at 1 h (Y1), in vitro drug release at 4 h (Y2), in vitro drug release at 8 h (Y3), and floating lag time (Y4). Results: The optimized formulation (F0) exhibits a floating lag time of around 70 ± 2 s and in vitro drug release of 99.89% at 12 h. The in vitro release of F1-F9 batches were found in between 99.87% and 84.43% at 12 h. Floating lag time of F1-F9 batches was found to be 36 ± 1 s–84 ± 3 s. Conclusion: HPMC K100 M and EC had a significant effect on floating lag time and in vitro drug release. Scanning electron microscope photomicrograph of pellets revealed that the surface was rough and the pellets were spherical shaped in nature. The in-vitro release kinetics revealed Korsmeyer-Peppas model is followed and drug release is by anomalous diffusion.","PeriodicalId":8489,"journal":{"name":"Asian Journal of Pharmaceutics","volume":" ","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2020-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Formulation and Evaluation of Gastroretentive Floating Pellets of Nizatidine\",\"authors\":\"Keyur S. Patel\",\"doi\":\"10.22377/ajp.v14i4.3818\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: The aim of the study was to develop gastroretentive floating pellets containing H2 –receptor antagonist, nizatidine which is primarily absorbed from stomach and has low oral bioavailability. Materials and Methods: The gastroretentive floating pellets of nizatidine were formulated using hydroxypropyl methylcellulose (HPMC) K100M and ethyl cellulose (EC) as sustained-release polymer, and NaHCO3 as a gas-forming agent. Pellets were prepared by extrusion–spheronization technique using microcrystalline cellulose as spheronizing agent. A 32 full factorial design was applied to investigate the effect of the two independent variables, that is, concentration of HPMC K100M (X1) and concentration of EC (X2) on the dependent variables, in vitro drug release at 1 h (Y1), in vitro drug release at 4 h (Y2), in vitro drug release at 8 h (Y3), and floating lag time (Y4). Results: The optimized formulation (F0) exhibits a floating lag time of around 70 ± 2 s and in vitro drug release of 99.89% at 12 h. The in vitro release of F1-F9 batches were found in between 99.87% and 84.43% at 12 h. Floating lag time of F1-F9 batches was found to be 36 ± 1 s–84 ± 3 s. Conclusion: HPMC K100 M and EC had a significant effect on floating lag time and in vitro drug release. Scanning electron microscope photomicrograph of pellets revealed that the surface was rough and the pellets were spherical shaped in nature. The in-vitro release kinetics revealed Korsmeyer-Peppas model is followed and drug release is by anomalous diffusion.\",\"PeriodicalId\":8489,\"journal\":{\"name\":\"Asian Journal of Pharmaceutics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2020-11-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Journal of Pharmaceutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22377/ajp.v14i4.3818\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22377/ajp.v14i4.3818","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

摘要

目的:本研究的目的是开发含有H2受体拮抗剂尼扎替丁的胃滞留漂浮颗粒,该颗粒主要从胃吸收,口服生物利用度低。材料与方法:以羟丙基甲基纤维素(HPMC)K100M和乙基纤维素(EC)为缓释聚合物,NaHCO3为成气剂,制备尼扎替丁胃滞留漂浮微丸。以微晶纤维素为滚圆剂,采用挤出滚圆技术制备了微丸。采用32全因子设计研究了HPMC K100M(X1)和EC(X2)浓度这两个自变量对因变量的影响,即1小时的体外药物释放(Y1)、4小时的体外药品释放(Y2)、8小时的体外用药释放(Y3)和漂浮滞后时间(Y4)。结果:优化后的制剂(F0)在12h时表现出约70±2s的漂浮滞后时间和99.89%的体外药物释放。F1-F9批次在12h时的体外释放率在99.87%至84.43%之间。F1-F九批次在36±1s–84±3s之间。结论:HPMC K100 M和EC对漂浮滞后时间及体外药物释放有显著影响。颗粒的扫描电子显微镜显微照片显示,颗粒表面粗糙,性质为球形。体外释放动力学表明,药物的释放遵循Korsmeyer-Peppas模型,并且是通过异常扩散释放的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Formulation and Evaluation of Gastroretentive Floating Pellets of Nizatidine
Aim: The aim of the study was to develop gastroretentive floating pellets containing H2 –receptor antagonist, nizatidine which is primarily absorbed from stomach and has low oral bioavailability. Materials and Methods: The gastroretentive floating pellets of nizatidine were formulated using hydroxypropyl methylcellulose (HPMC) K100M and ethyl cellulose (EC) as sustained-release polymer, and NaHCO3 as a gas-forming agent. Pellets were prepared by extrusion–spheronization technique using microcrystalline cellulose as spheronizing agent. A 32 full factorial design was applied to investigate the effect of the two independent variables, that is, concentration of HPMC K100M (X1) and concentration of EC (X2) on the dependent variables, in vitro drug release at 1 h (Y1), in vitro drug release at 4 h (Y2), in vitro drug release at 8 h (Y3), and floating lag time (Y4). Results: The optimized formulation (F0) exhibits a floating lag time of around 70 ± 2 s and in vitro drug release of 99.89% at 12 h. The in vitro release of F1-F9 batches were found in between 99.87% and 84.43% at 12 h. Floating lag time of F1-F9 batches was found to be 36 ± 1 s–84 ± 3 s. Conclusion: HPMC K100 M and EC had a significant effect on floating lag time and in vitro drug release. Scanning electron microscope photomicrograph of pellets revealed that the surface was rough and the pellets were spherical shaped in nature. The in-vitro release kinetics revealed Korsmeyer-Peppas model is followed and drug release is by anomalous diffusion.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Asian Journal of  Pharmaceutics
Asian Journal of Pharmaceutics PHARMACOLOGY & PHARMACY-
自引率
0.00%
发文量
47
期刊介绍: Character of the publications: -Pharmaceutics and Pharmaceutical Technology -Formulation Design and Development -Drug Discovery and Development Interface -Manufacturing Science and Engineering -Pharmacokinetics, Pharmacodynamics, and Drug Metabolism -Clinical Pharmacology, General Medicine and Translational Research -Physical Pharmacy and Biopharmaceutics -Novel Drug delivery system -Biotechnology & Microbiological evaluations -Regulatory Sciences
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信